HPX and neoplasm: In summary, our analysis indicates, on one side, that the concentration of GLRA1-3 mutations across TM1 and TM2 is very likely not random, and, on the other, that these changes certainly disrupt the GlyR function in the tumor cells carrying them, as seen for HPX.